Company / Current Assets per Share
NovaBay Pharmaceuticals, Inc. Current Assets per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$0.40
FY2024
5-year range
$0.30 / $5.57
FY2020-FY2024
Trend
-37.8%
vs FY2023
Sector context
#207 of 212
Health Care
What the data says
Among 212 Health Care companies, NovaBay Pharmaceuticals, Inc. is in the bottom 2% for current assets per share. Current Assets per Share has fluctuated over the past 10 years, ranging from $0.30 in FY2021 to $5.57 in FY2022.
Based on SEC 10-K filings.
0.40 in FY2024 with a 5-year CAGR of -1.8%.
Declined from $5.57 to $0.40 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +9.5%
- 5-Year CAGR
- -1.8%
- 10-Year CAGR
- -
Sector benchmark
Bottom 2% in Health CareTop 98% of 212This company $0.40 Sector average $133.20
▼
-99.7% below sector average
Key checks
Key Insights
- In FY2024, current assets per share decreased 37.8% year-over-year.
- Ranks #207 out of 212 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2022.
- Lowest current assets per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -5.51 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.40 | -37.8% |
| FY2023 | $0.64 | -88.6% |
| FY2022 | $5.57 | +1745.9% |
| FY2021 | $0.30 | -25.7% |
| FY2020 | $0.41 | -6.3% |
| FY2019 | $0.43 | -14.1% |
| FY2018 | $0.50 | -14.3% |
| FY2017 | $0.59 | -85.8% |
| FY2016 | $4.15 | +89.4% |
| FY2015 | $2.19 | +1306.5% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026